Integrating Primary Care Services in the Family Planning Clinic: Impact on Reproductive Health Care
Method. A quasi-experimental design compared outcomes from the clinic of interest (Belfast) with those of two matched clinics that were family planning only (Rockland and Waterville). We compared data from electronic medical records from the baseline year (2013) to the first year of the integrated service (2014).
Results. In Belfast, family planning appointments increased by 14%, whereas Rockland and Waterville appointments decreased by 8% and 9%, respectively. Overall, an additional 2% of patients at Belfast reported using some form of contraception, while this number declined by 3% and 4% at Rockland and Waterville. All clinics reported significantly more patients using “most effective methods” (sterilization and LARC). This increase was largest at Belfast, at 66%, and was explained by a steep increase in hormonal implants. Belfast saw significantly more males, and 28% more patients reported use of condoms. Referrals for mammograms and ultrasounds more than doubled in Belfast, although they also increased in the Rockland clinic.
Implications: Integrating additional health services into this family planning clinic allowed the clinic to provide more family planning services and address reproductive health issues of patients who came in for primary care services. Contraceptive use and effectiveness increased, as did the referral volume for reproductive health needs.
Learning Areas:Conduct evaluation related to programs, research, and other areas of practice
Provision of health care to the public
Describe how integrated primary care services affected the reproductive health care function of a family planning clinic.
Keyword(s): Contraception, Reproductive Health
Qualified on the content I am responsible for because: I am the lead evaluator on this multi-year, multi-site project. I am also lead evaluator on several other projects in health and education.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.